2158|50|Public
5|$|Other NAD-dependent enzymes include {{bacterial}} DNA ligases, which join two DNA ends {{by using}} NAD {{as a substrate}} to donate an <b>adenosine</b> <b>monophosphate</b> (AMP) moiety to the 5' phosphate of one DNA end. This intermediate is then attacked by the 3' hydroxyl group of the other DNA end, forming a new phosphodiester bond. This contrasts with eukaryotic DNA ligases, which use ATP to form the DNA-AMP intermediate.|$|E
5|$|Carbon dioxide (CO2), <b>adenosine</b> <b>mono{{phosphate}}</b> (AMP) and phosphate groups (PP) {{are released}} as waste products. Luciferase catalyzes the reaction, {{which may be}} mediated by cofactors such as calcium (Ca2+) or magnesium (Mg2+) ions, and for some types of luciferin (L) also the energy-carrying molecule adenosine triphosphate (ATP). The reaction can occur either inside or outside the cell. In bacteria such as Aliivibrio, the expression of genes related to bioluminescence {{is controlled by the}} lux operon.|$|E
5|$|Metformin {{decreases}} {{high blood}} sugar, primarily by suppressing liver glucose production (hepatic gluconeogenesis). The average patient with {{type 2 diabetes}} has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one-third. The molecular mechanism of metformin is incompletely understood. Multiple potential mechanisms of action have been proposed, including; inhibition of the mitochondrial respiratory chain (complex I), activation of AMP-activated protein kinase (AMPK), inhibition of glucagon-induced elevation of cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP) with reduced activation of protein kinase A (PKA), inhibition of mitochondrial glycerophosphate dehydrogenase, and an effect on gut microbiota.|$|E
50|$|One {{example of}} {{crosstalk}} between proteins in a signalling pathway {{can be seen}} with cyclic <b>adenosine</b> <b>monophosphate's</b> (cAMP) role in regulating cell proliferation by interacting with the mitogen-activated protein (MAP) kinase pathway. cAMP is a compound synthesized in cells by adenylate cyclase {{in response to a}} variety of extracellular signals. cAMP primarily acts as an intracellular second messenger whose major intracellular receptor is the cAMP-dependent protein kinase (PKA) that acts through the phosphorylation of target proteins. The signal transduction pathway begins with ligand-receptor interactions extracellularly. This signal is then transduced through the membrane, stimulating adenylyl cyclase on the inner membrane surface to catalyze the conversion of ATP to cAMP.|$|R
40|$|Results are {{presented}} for an experimental study intended to assess phosphorylation under neither aqueous nor dry thermal conditions. Instead, phosphorylations were attempted in possible nonaqueous prebiotic solvents. Formamide {{appeared to be}} the most obvious candidate for phosphorylation studies. Three main classes of phosphorylated products were formed in formamide solution: <b>adenosine</b> <b>monophosphates,</b> cyclic <b>adenosine</b> phosphate, and adenosine diphosphates. Experiments were designed to investigate the extent of phosphorylation of nucleosides in formamide, the relative amounts of nucleoside monophosphate, diphosphates and cyclic phosphate formed and the relative effectiveness of different sources of phosphate as phosphorylating agents in formamide. Reaction variables were temperature, nature of the phosphate or condensed phosphate, nucleoside, concentration of reactants and possible effects of additives. Product identification was based on qualitative and quantitative thin layer chromatography...|$|R
40|$|The β 2 -adrenergic {{receptor}} (β 2 AR) is a prototypical Gs-coupled receptor {{belonging to}} the superfamily of seven transmembrane spanning heptahelical receptors (7 TMRs or G protein-coupled receptors [GPCRs]) —therapeutically the most diverse and accessible class of cell surface receptors. The classic pathway of β 2 AR signaling (Fig. 1) is triggered by activation of the heterotrimeric G protein Gs by agonists (catecholamines—noradrenaline and adrenaline). This in turn activates adenylyl cyclase leading to the generation of second messenger signaling molecules (cyclic <b>adenosine</b> <b>monophosphates,</b> cAMP) which subsequently activate protein kinase A (PKA) {{as well as some}} ion channels, such as the class C type of L-type calcium channels, Cav 1. 2. 31 Here in we review how trafficking and signaling of the β 2 AR is regulated by the post-translational modification, ubiquitination. ...|$|R
5|$|Activation of AMPK was {{required}} for metformin's inhibitory effect on liver glucose production. AMPK is an enzyme that {{plays an important role}} in insulin signaling, whole body energy balance and the metabolism of glucose and fats. AMPK Activation {{was required}} for an increase in the expression of small heterodimer partner, which in turn inhibited the expression of the hepatic gluconeogenic genes phosphoenolpyruvate carboxykinase and glucose 6-phosphatase. Metformin is frequently used in research along with AICA ribonucleotide as an AMPK agonist. Mouse models in which the genes for AMPKα1 and α2 catalytic subunits (Prkaa1/2) or LKB1, an upstream kinase of AMPK, had been knocked out in hepatocytes, have raised doubts over the role of AMPK, since the effect of metformin was not abolished by loss of AMPK function. The mechanism by which biguanides increase the activity of AMPK remains uncertain; however, metformin increases the concentration of cytosolic <b>adenosine</b> <b>monophosphate</b> (AMP) (as opposed to a change in total AMP or total AMP/adenosine triphosphate). Increased cellular AMP has been proposed to explain the inhibition of glucagon-induced increase in cAMP and activation of PKA. Metformin and other biguanides may antagonize the action of glucagon, thus reducing fasting glucose levels. Metformin also induces a profound shift in the faecal microbial community profile in diabetic mice and this may contribute to its mode of action possibly through an effect on glucagon-like peptide-1 secretion.|$|E
25|$|Gsα {{subsequently}} activates adenylyl cyclase, {{increasing the}} intracellular {{concentration of the}} second messenger cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP).|$|E
25|$|Therefore, for cAMP, 3’5’-cyclic <b>adenosine</b> <b>monophosphate</b> {{indicates}} that a single phosphate group forms a cyclic structure with the ribose group at its 3’ and 5’ carbons, while the ribose group is also attached to adenosine (this bond is understood {{to be at the}} 1’ position of the ribose).|$|E
5000|$|W. Kadima, P. Raharivelomanana and B. Bechtel: The binding of cyclic <b>adenosine</b> 3′, 5′ <b>monophosphate</b> to the insulin hexamer. Jan 1997, Protein and Peptide Letters.|$|R
50|$|Adenine is {{converted}} to <b>adenosine</b> or inosine <b>monophosphate</b> (IMP), either of which, in turn, {{is converted}} into inosine (I), which pairs with adenine (A), cytosine (C), and uracil (U).|$|R
5000|$|... 5'-Nucleotidases cleave off the {{phosphate}} {{from the}} 5' {{end of the}} sugar moiety. They can be classified into various kinds depending on their substrate preferences and subcellular localization. Membrane-bound 5'-nucleotidases display specificity toward <b>adenosine</b> <b>monophosphates</b> and are involved predominantly in the salvage of preformed nucleotides and in signal transduction cascades involving purinergic receptors. Soluble 5'-nucleotidases are all known {{to belong to the}} haloacid dehalogenase superfamily of enzymes, which are two domain proteins characterised by a modified Rossman fold as the core and variable cap or hood. The soluble forms are further subclassified based on the criterion mentioned above. mdN and cdN are mitochondrial and cytosolic 5'-3'-pyrimidine nucleotidases. cN-I is a cytosolic nucleotidase(cN) characterized by its affinity toward AMP as its substrate. cN-II is identified by its affinity toward either IMP or GMP or both. cN-III is a pyrimidine 5'-nucleotidase. 5'-Nucleotidases are involved in varied functions like cell-cell communication, nucleic acid repair, purine salvage pathway for the synthesis of nucleotides, signal transduction, membrane transport, etc.|$|R
25|$|Arginine is {{synthesized}} from citrulline in arginine and proline metabolism by the sequential {{action of}} the cytosolic enzymes argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL). This is an energetically costly process, because for each molecule of argininosuccinate that is synthesized, one molecule of adenosine triphosphate (ATP) is hydrolyzed to <b>adenosine</b> <b>monophosphate</b> (AMP), consuming two ATP equivalents.|$|E
25|$|There are {{two main}} {{receptor}} types associated with the endocannabinoid signaling system; cannabinoid receptor 1 (CB1) and 2 (CB2). Both receptors are 7-transmembrane G-protein coupled receptors (GPCRs) which inhibit the accumulation of cyclic <b>adenosine</b> <b>monophosphate</b> within cells. CB1 receptors are present in highest concentration in the brain but {{can also be found}} in the periphery. CB2 receptors are mostly located in the immune and haematopoietic systems.|$|E
25|$|Numerous melanocortin, MCH and {{melatonin}} receptors {{have been}} identified in fish and frogs, including a homologue of MC1R, a melanocortin receptor known to regulate skin and hair colour in humans. It has been demonstrated that MC1R is required in zebrafish for dispersion of melanin. Inside the cell, cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP) {{has been shown to be}} an important second messenger of pigment translocation. Through a mechanism not yet fully understood, cAMP influences other proteins such as protein kinase A to drive molecular motors carrying pigment containing vesicles along both microtubules and microfilaments.|$|E
40|$|AbstractThe goal of {{this work}} is to {{determine}} the proton affinities of (deoxy) nucleoside 5 ′- and 3 ′-monophosphates (mononucleotides) using the kinetic method with fast atom bombardment mass spectrometry. The proton affinities of the (deoxy) nucleoside 5 ′- and 3 ′-monophosphates yielded the following trend: (deoxy) <b>adenosine</b> <b>monophosphates</b> > (deoxy) guanosine monophosphates > (deoxy) cytidine monophosphates ≫ deoxythymidine/uridine monophosphates. In all cases the proton affinity decreases or remains the same with the addition of the phosphate group from those values reported for nucleosides. The proton affinity is dependent on the location of the phosphate backbone (5 ′- vs. 3 ′-phosphates) : the 3 ′-monophosphates have lower proton affinities than the 5 ′-monophosphates except for the thymidine/uridine monophosphates where the trend is reversed. Molecular modeling was utilized to determine if multiple protonation sites and intramolecular hydrogen bond formation would influence the proton affinity measurements. Semiempirical calculations of the proton affinities at various locations on each mononucleotide were performed and compared to the experimental results. The possible influence of intramolecular hydrogen bonding between the nucleobases and the phosphate group on the measured and calculated proton affinities is discussed...|$|R
50|$|Soluble adenylyl cyclase (sAC) is a {{regulatory}} cytosolic enzyme present {{in almost every}} cell. sAC {{is a source of}} cyclic <b>adenosine</b> 3’,5’ <b>monophosphate</b> (cAMP) - a second messenger that mediates cell growth and differentiation in organisms from bacteria to higher eukaryotes. sAC differentiates from the transmembrane adenylyl cyclase (tmACs) - an important source of cAMP; in that sAC is regulated by bicarbonate anions and it is dispersed throughout the cell cytoplasm. sAC has been found to have various functions in physiological systems {{different from that of the}} tmACs.|$|R
40|$|Extracellular {{adenosine}} is {{a potent}} immunosuppressor that accumulates during tumor growth. We performed proof-of-concept studies investigating the therapeutic potential and mechanism of action of monoclonal antibody (mAb) -based therapy against CD 73, an ecto-enzyme overexpressed on breast-cancer cells that catalyzes the dephosphorylation of <b>adenosine</b> <b>monophosphates</b> into <b>adenosine.</b> We showed that anti-CD 73 mAb therapy significantly delayed primary 4 T 1. 2 and E 0771 tumor growth in immune-competent mice and significantly inhibited the development of spontaneous 4 T 1. 2 lung metastases. Notably, anti-CD 73 mAb therapy was essentially dependent on the induction of adaptive anti-tumor immune responses. Knockdown of CD 73 in 4 T 1. 2 tumor cells confirmed the tumor-promoting effects of CD 73. In addition to its immunosuppressive effect, CD 73 enhanced tumor-cell chemotaxis, suggesting a role for CD 73 -derived adenosine in tumor metastasis. Accordingly, administration of adenosine- 5 ′-N-ethylcarboxamide to tumor-bearing mice significantly enhanced spontaneous 4 T 1. 2 lung metastasis. Using selective adenosine-receptor antagonists, we showed that activation of A 2 B adenosine receptors promoted 4 T 1. 2 tumor-cell chemotaxis in vitro and metastasis in vivo. In conclusion, our study identified tumor-derived CD 73 as a mechanism of tumor immune escape and tumor metastasis, and it also established the proof of concept that targeted therapy against CD 73 can trigger adaptive anti-tumor immunity and inhibit metastasis of breast cancer...|$|R
25|$|Direct {{sympathetic}} innervation of the {{salivary glands}} takes place via preganglionic nerves in the thoracic segments T1-T3 which synapse in the superior cervical ganglion with postganglionic neurons that release norepinephrine, {{which is then}} received by β-adrenergic receptors on the acinar and ductal cells of the salivary glands, leading {{to an increase in}} cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP) levels and the corresponding increase of saliva secretion. Note that in this regard both parasympathetic and sympathetic stimuli result in an increase in salivary gland secretions. The sympathetic nervous system also affects salivary gland secretions indirectly by innervating the blood vessels that supply the glands.|$|E
25|$|Earl Wilbur Sutherland won the 1971 Nobel Prize in Physiology or Medicine ″for his discoveries {{concerning}} {{the mechanisms of}} the action of hormones″, in particular the discovery of cyclic <b>adenosine</b> <b>monophosphate</b> as second messenger in the action of catecholamines at β-adrenoceptors and of glucagon at glucagon receptors, which led on {{to the discovery of}} heterotrimeric G proteins. In 1988 James Black was one of three winners of the Nobel Prize in Physiology or Medicine ″for their discoveries of important principles for drug treatment″, Black’s ″important principles″ being the blockade of β-adrenoceptors and of histamine H2 receptors. In 2012, Robert Lefkowitz and Brian Kobilka shared the Nobel Prize in Chemistry ″for studies of G-protein-coupled receptors″.|$|E
25|$|The binding of {{melatonin}} to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition {{causes a}} rippling effect of non activation; starting with decreasing formation of cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP), and then progressing to less protein kinase A (PKA) activity, {{which in turn}} hinders the phosphorylation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP. As well it hinders guanylyl cyclase and therefore the forming of cyclic guanosine monophosphate (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.|$|E
50|$|Spot42 {{was first}} {{described}} in 1973 as an unstable RNA species of 109 nucleotides in Escherichia coli. It {{was discovered by}} polyacrylamide gel electrophoresis and 2-D fingerprinting {{in an attempt to}} study the accumulation of small RNAs in E. coli during amino acid starvation. In these experiments the electrophoretic mobility of Spot42 was similar to that of 5S rRNA. In 1979 Spot42 was found to accumulate under growth in the presence of glucose (i.e., when <b>adenosine</b> 3′,5′-cyclic <b>monophosphate</b> (cAMP) is low). During growth with a non-glucose carbon source (i.e., when cAMP concentrations are high) the Spot42 concentrations were found to be significantly lower.|$|R
50|$|In some occasions, DNA and RNA {{may contain}} some minor bases. Methylated {{forms of the}} major bases are most common in DNA. In viral DNA, some bases may be hydroxymethylated or glucosylated. In RNA, minor or {{modified}} bases occur more frequently. Some examples include hypoxanthine, dihydrouracil, methylated forms of uracil, cytosine, and guanine, as well as modified nucleoside pseudouridine. Nucleotides with phosphate groups in positions other than on the 5' carbon have also been observed. Examples include ribonucleoside 2',3'-cyclic monophosphates which are isolatable intermediates, and ribonucleoside 3'-monophosphates which are end products of the hydrolysis of RNA by certain ribonucleases. Other variations include <b>adenosine</b> 3',5'-cyclic <b>monophosphate</b> (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP).|$|R
40|$|AbstractBackgroundBinding of {{adhesive}} proteins (i. e., fibrinogen, fibronectin, vitronectin) to platelet integrin glycoprotein IIb/IIIa (αIIb/β 3) {{by various}} agonists (thrombin, collagen, adenosine diphosphate) involve in strength of thrombus. This study {{was carried out}} to evaluate the antiplatelet effect of total saponin from Korean Red Ginseng (KRG-TS) by investigating whether KRG-TS inhibits thrombin-induced binding of fibrinogen and fibronectin to αIIb/β 3. MethodsWe investigated the effect of KRG-TS on phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and dephosphorylation of phosphatidylinositol 3 -kinase (PI 3 K) and Akt, affecting binding of fibrinogen and fibronectin to αIIb/β 3, and clot retraction. ResultsKRG-TS had an antiplatelet effect by inhibiting the binding of fibrinogen and fibronectin to αIIb/β 3 via phosphorylation of VASP (Ser 157), and dephosphorylation of PI 3 K and Akt on thrombin-induced platelet aggregation. Moreover, A-kinase inhibitor Rp- 8 -Br-cyclic <b>adenosine</b> <b>monophosphates</b> (cAMPs) reduced KRG-TS-increased VASP (Ser 157) phosphorylation, and increased KRG-TS-inhibited fibrinogen-, and fibronectin-binding to αIIb/β 3. These findings indicate that KRG-TS interferes with the binding of fibrinogen and fibronectin to αIIb/β 3 via cAMP-dependent phosphorylation of VASP (Ser 157). In addition, KRG-TS decreased the rate of clot retraction, reflecting inhibition of αIIb/β 3 activation. In this study, we clarified ginsenoside Ro (G-Ro) in KRG-TS inhibited thrombin-induced platelet aggregation via both inhibition of [Ca 2 +]i mobilization and increase of cAMP production. ConclusionThese results strongly indicate that KRG-TS is a beneficial herbal substance inhibiting fibrinogen-, and fibronectin-binding to αIIb/β 3, and clot retraction, and may prevent platelet αIIb/β 3 -mediated thrombotic disease. In addition, we demonstrate that G-Ro is a novel compound with antiplatelet characteristics of KRG-TS...|$|R
25|$|Phosphodiesterase 4 is {{a member}} of the {{phosphodiesterase}} family of proteins that cleave phosphodiester bonds. This is an important step in degrading cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP), a major intracellular signaling molecule; conversely, blocking PDE4 will increase cAMP. Increased intracellular cAMP levels in neurons has been previously shown to induce axonal growth. In 2004, Nikulina et al. showed that administration of rolipram, a PDE4 inhibitor, can increase cAMP levels in neurons after spinal cord injury. This is partially possible because rolipram is sufficiently small to pass through the blood–brain barrier and immediately begin to catalyze reactions in neurons. 10 day administration of rolipram in spinal cord injured rodents resulted in considerable axonal growth associated with a reduction in glial scarring at 2 weeks post-injury. The mechanism for this reduction in glial scarring is currently unknown, but possible mechanisms include axonal extensions that physically prevent reactive astrocytes from proliferating, as well as chemical signaling events to reduce reactive astrogliosis.|$|E
25|$|Energy {{needed to}} perform short lasting, high {{intensity}} bursts of activity {{is derived from}} anaerobic metabolism within the cytosol of muscle cells, as opposed to aerobic respiration which utilizes oxygen, is sustainable, and occurs in the mitochondria. The quick energy sources consist of the phosphocreatine (PCr) system, fast glycolysis, and adenylate kinase. All of these systems re-synthesize adenosine triphosphate (ATP), which is the universal energy source in all cells. The most rapid source, but the most readily depleted of the above sources is the PCr system which utilizes the enzyme creatine kinase. This enzyme catalyzes a reaction that combines phosphocreatine and adenosine diphosphate (ADP) into ATP and creatine. This resource is short lasting because oxygen {{is required for the}} resynthesis of phosphocreatine via mitochondrial creatine kinase. Therefore, under anaerobic conditions, this substrate is finite and only lasts between approximately 10 to 30 seconds of high intensity work. Fast glycolysis, however, can function for approximately 2 minutes prior to fatigue, and predominately uses intracellular glycogen as a substrate. Glycogen is broken down rapidly via glycogen phosphorylase into individual glucose units during intense exercise. Glucose is then oxidized to pyruvate and under anaerobic condition is reduced to lactic acid. This reaction oxidizes NADH to NAD, thereby releasing a hydrogen ion, promoting acidosis. For this reason, fast glycolysis can not be sustained for long periods of time. Lastly, adenylate kinase catalyzes a reaction by which 2 ADP are combined to form ATP and <b>adenosine</b> <b>monophosphate</b> (AMP). This reaction takes place during low energy situations such as extreme exercise or conditions of hypoxia, but is not a significant source of energy. The creation of AMP resulting from this reaction stimulates AMP-activated protein kinase (AMP kinase) which is the energy sensor of the cell. After sensing low energy conditions, AMP kinase stimulates various other intracellular enzymes geared towards increasing energy supply and decreasing all anabolic, or energy requiring, cell functions.|$|E
500|$|The DNA {{double helix}} is {{stabilized}} primarily by two forces: hydrogen bonds between nucleotides and base-stacking interactions among aromatic nucleobases. In the aqueous {{environment of the}} cell, the conjugated [...] bonds of nucleotide bases align perpendicular to the axis of the DNA molecule, minimizing their interaction with the solvation shell. The four bases found in DNA are adenine (A), cytosine (C), guanine (G) and thymine (T). These four bases {{are attached to the}} sugar-phosphate to form the complete nucleotide, as shown for <b>adenosine</b> <b>monophosphate.</b> Adenine pairs with thymine and guanine pairs with cytosine. It was represented by A-T base pairs and G-C base pairs.|$|E
40|$|This paper {{reports the}} growth and {{differentiation}} of the mouse embryonal carcinoma cell line F 9 in completely defined culture media. The defined growth medium, referred to as EM- 3, contains plasma fibronectin, insulin, and transferrin in place of serum. F 9 cells cultured in EM- 3 for over 15 generations retain their ability to form tumors and to differentiate. Fibronectin {{is essential for the}} attachment of F 9 cells in defined media and its effect can be blocked with affinity-purified anti-fibronectin. When retinoic acid was added to EM- 3, the F 9 cells differentiated. The majority of the the newly formed cells differed from patient F 9 cell two major respects: (i) they were morphologically different; and (ii) they secreted plasminogen activator, and the secretion was stimulated by dibutyrlyl <b>adenosine</b> cyclic <b>monophosphate...</b>|$|R
40|$|Differentiation {{of human}} promyelocytic leukemia cells (HL- 60) in {{response}} to several classes of inducing agents {{is characterized by the}} sequential appear-ance of granulocytic or monocytic markers. Compounds that increase intracel-lular cAMP in HL- 60 cells induce a program of maturation in which cells demonstrate early functional phagocytic properties. Cyclic nucleotide metabolism was studied during monocytic and granulo-cytic differentiation of the HL- 60 cell line. In synchronous and nonsynchronous cell cultures, cyclic AMP levels were raised 300 -fold or 25 -fold {{in response to}} N 6, 02 -dibutyryl <b>adenosine</b> 3 ’:S’-cyclic <b>monophosphate</b> or the combination of prostaglandin E 2 and theophylline, respectively. No reproducible changes in intracellular adenosine 3 ’: 5 ’-cyclic monophosphate levels occurred in re-sponse to retinoic acid or dimethyl sulfoxide, suggesting that changes in <b>adenosine</b> 3 ’:S’-cyclic <b>monophosphate</b> levels alone do not mediate cell matur-ation induced by these compounds. Agents that increased intracellular cyclic AMP in HL- 60 cells slowed the progress through the S and G 2 -M phase of the cell cycle, whereas other agents such as dimethyl sulfoxide stimulated cells through this same period. Key words: leukemia, differentiation, cAMP, cell cycl...|$|R
30|$|Several other HU-mediated {{mechanisms}} of disease amelioration {{have been reported}} including production of nitric oxide, regulation of soluble guanylyl cyclase, cyclic <b>adenosine</b> and guanosine <b>monophosphate</b> [36, 37] as well as erythropoietic stress response [38]. Furthermore, various signalling pathways have been implicated in HU-mediated fetal hemoglobin (HbF) induction such as the Giα/JNK/Jun [39]; p 38 /MAPK/CREB 1 [40]; cAMP-mediated response [41, 42]; erythropoietin (EPO)-induced activation of the ERK- 1 /ERK- 2 MAPK [43]; histone deacetylase (HDAC) and DNA methyl-transferase (DNMT) inhibitor-mediated epigenetic modification of γ-globin expression. Despite this, a complete understanding of HU-mediated HbF production remains incomplete.|$|R
500|$|When the RNA is cleaved, {{polyadenylation}} starts, catalysed by polyadenylate polymerase. Polyadenylate polymerase {{builds the}} poly(A) tail by adding <b>adenosine</b> <b>monophosphate</b> units from adenosine triphosphate to the RNA, cleaving off pyrophosphate. Another protein, PAB2, binds to the new, short poly(A) tail {{and increases the}} affinity of polyadenylate polymerase for the RNA. When the poly(A) tail is approximately 250 nucleotides long the enzyme can no longer bind to CPSF and polyadenylation stops, thus determining {{the length of the}} poly(A) tail. CPSF is in contact with RNA polymerase II, allowing it to signal the polymerase to terminate transcription. When RNA polymerase II reaches a [...] "termination sequence" [...] (TTATTT on the DNA template and AAUAAA on the primary transcript), the end of transcription is signaled. The polyadenylation machinery is also physically linked to the spliceosome, a complex that removes introns from RNAs.|$|E
2500|$|The {{two most}} well-studied cyclic {{nucleotides}} are cyclic AMP (cAMP) and cyclic GMP (cGMP), while cyclic CMP (cCMP) and cyclic UMP (cUMP) are less understood. [...] cAMP is 3’5’-cyclic <b>adenosine</b> <b>monophosphate,</b> cGMP is 3’5’-cyclic guanosine monophosphate, cCMP is cytidine 3',5'-monophosphate, and cUMP is uridine 2',3'-cyclic phosphate.|$|E
2500|$|A cyclic {{nucleotide}} (cNMP) is a single-phosphate nucleotide with a cyclic bond arrangement {{between the}} sugar and phosphate groups. [...] Like other nucleotides, cyclic nucleotides are composed of three functional groups: a sugar, a nitrogenous base, and a single phosphate group. [...] As {{can be seen in}} the cyclic <b>adenosine</b> <b>monophosphate</b> (cAMP) and cyclic guanosine monophosphate (cGMP) images, the 'cyclic' portion consists of two bonds between the phosphate group and the 3' and 5' hydroxyl groups of the sugar, very often a ribose.|$|E
40|$|AbstractLow-density lipoproteins {{activate}} isolated human platelets. The {{mechanism of}} this activation is unknown, but may involve increased phosphoinositide turnover. We {{have examined the}} effect of low-density lipoproteins on intracellular calcium concentrations in platelets loaded with the photoprotein aequorin. The lipoproteins induced concentration-dependent increases in intracellular calcium, associated with shape change and aggregation. These responses could be partially inhibited by the removal of extracellular calcium and by pre-incubation with acetylsalicylic acid. They were also antagonised by agents which increase cellular concentrations of cyclic <b>adenosine</b> and guanosine <b>monophosphates.</b> It {{is not clear whether}} the platelet-lipoprotein interaction involves a ‘classical’ lipoprotein receptor...|$|R
40|$|Dog hearts were {{harvested}} {{and stored}} cold (0. 5 degree C) for 24 -hours. Cardiac arrest was induced {{by means of}} low-sodium and calcium-free cardioplegic (n = 6) or hyperkalemic cardioplegic (n = 6) solution. Nifedipine (2 micrograms/gm estimated heart weight) was added to each cardioplegic solution in two additional groups (n = 6 each). High energy phosphates (creatine phosphate and adenosine triphosphate) and catabolites (<b>adenosine</b> diphosphate and <b>monophosphate,</b> <b>adenosine,</b> inosine, hypoxanthine, xanthine) were determined in the myocardium before and during 24 hours of cold storage. With use of the standard hyperkalemic cardioplegic solution, breakdown of high energy phosphates was less pronounced than after {{the use of a}} low sodium, calcium-free solution: after 24 hours of cold storage myocardial ATP content was 57 % of control versus 32 % (p less than 0. 05). The addition of nifedipine to the hyperkalemic cardioplegic solution delayed ATP breakdown during the first hours of cold storage: at 5 hours of preservation the myocardial ATP level was significantly higher (p less than 0. 05) than in hearts preserved without nifedipine. Addition of nifedipine to the low-sodium, calcium-free solution did not influence catabolism of high energy phosphates significantly. It is concluded that preservation of high energy phosphates during long-term cold storage of donor hearts can be best achieved by simultaneous myocardial metabolic blockade at two specific sites: at the "fast" sodium-potassium channels by hyperkalemic depolarization and at the "slow" channels by means of calcium channel blockers. status: publishe...|$|R
2500|$|In E. coli Spot 42 accumulates under {{growth in}} the {{presence}} of glucose (i.e., when <b>adenosine</b> 3′,5′-cyclic <b>monophosphate</b> (cAMP) is low). The direct responsiveness of Spot 42 levels to glucose and cAMP is due to repression of spf expression by a cAMP-CRP (cAMP-receptor protein) complex. Spot42 is found in 100 – 200 copies per cell when cells are grown in glucose, and is reduced 3-4 folds when cells are grown in succinate (a secondary carbon sources). The reduction of Spot42 in cells grown in secondary carbon sources is a result of binding of the cAMP-CRP complex to the spf promoter, which negatively regulates transcription of Spot42. Later, the proximity of spf to polA (gene encoding DNA polymerase I) led Polayes and co-workers to test whether the products of these genes could influence each other. They found that by reducing levels of Spot 42, either by deletion of spf or by manipulating the growth conditions, the DNA pol A activity was reduced. The underlying mechanism for this observation remains however unknown.|$|R
